semaglutide risks side effects for diabetes and obesity treatment Tirzepatide vs. Semaglutide: What You

Long-term side effects can include medullary thyroid cancer, he added

Semaglutide, a GLP-1 receptor agonist, slows stomach emptying, increases feelings of fullness, and prompts the pancreas to release insulin only when blood sugar is elevated

Such rigorous evaluations involved reviewing extensive clinical data, ensuring that the medication could provide substantial benefits for individuals struggling with obesity

That mechanism makes Contrave a reasonable option for patients where a stimulant or controlled medication would be clinically inappropriate

Some providers recommend temporary caloric cycling, alternating between slightly higher and lower intake days, to prevent metabolic adaptation